mRNA-transfected dendritic cell vaccine in combination with metronomic cyclophosphamide as treatment for patients with advanced malignant melanoma

Introduction: Vaccination with dendritic cells (DCs) has generally not fulfilled its promise in cancer immunotherapy due to ineffective translation of immune responses into clinical responses. A proposed reason for this is intrinsic immune regulatory mechanisms, such as regulatory T cells (Tregs). A...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:Oncoimmunology
Auteurs principaux: Borch, Troels Holz, Engell-Noerregaard, Lotte, Zeeberg Iversen, Trine, Ellebaek, Eva, Met, Özcan, Hansen, Morten, Andersen, Mads Hald, thor Straten, Per, Svane, Inge Marie
Format: Artigo
Langue:Inglês
Publié: Taylor & Francis 2016
Sujets:
MIATA Compliant Research Paper
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC5048758/
https://ncbi.nlm.nih.gov/pubmed/27757300
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/2162402X.2016.1207842
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires